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Alzheimer’s disease (AD) is a neurodegenerative disorder with cognitive impairment. Physical exercise has long been proven to be
beneficial in the disorder. The present study was designed to examine the effect of voluntary exercise on spatial memory, imaging,
and pathological abnormalities. Particular focus has been given to the role of heme oxygenase-1 (HO-1)—an important cellular
cytoprotectant in preserving mental acuity—using an aging rat model of dementia. Male and female Wistar rats were segregated
into six groups—namely, (i) aged sedentary (control) females (ASF, 𝑛 = 8); (ii) aged sedentary (control) males (ASM, 𝑛 = 8); (iii)
aged running females (ARF, 𝑛 = 8); (iv) aged running males (ARM, 𝑛 = 8); (v) young control females (YCF, 𝑛 = 8); and (vi)
young control males (YCM, 𝑛 = 8). Rats in the ARF and ARM groups had free access to a standardized inbuilt running wheel
during the 3-month evaluation period. Spatial memory was investigated using the Morris Water Test, imaging and pathological
alterations were assessed using positron emission tomography (PET) imaging and histopathological examinations (H&E, Congo
red staining), respectively, and HO-1 enzyme activity assays were also conducted. The outcomes suggest that voluntary physical
exercise mitigates impaired spatial memory and neuropathological changes exhibited by the aging sedentary group, via elevated
HO-1 activity, contributing to the antioxidant capacity in the aging brain.
1. Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder, with neuropathology characterized by the accu-
mulation of extracellular amyloid plaques and intracellular
neurofibrillary tangles. In 2016, Alzheimer’s Disease Interna-
tional, an organization founded to promote efforts to prevent
and treat the disease, issued their World Alzheimer’s Report,
which estimates that 46.8 million people worldwide were
living with AD, with 131.5 million projected to be afflicted
by 2050 [1]. Changes in demographic patterns, principally
increasing life expectancy, with resulting increases in elderly
populations, have resulted in a concomitant expansion of
AD-afflicted individuals and an increased burden on national
healthcare systems. According to Alzheimer’s Association,
AD is the 6th leading cause of death in the USA, with 1 out of
every 3 elderly people succumbing to it in 2016. In that year,
the estimated fiscal cost of the disease was 236 billion dollars,
which is forecast to increase to a trillion dollars annually
by 2050. These factors notwithstanding, the development of
effective countermeasures for AD remains elusive at the time
of this writing [1].
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Although comprehensively definitive descriptions of AD
pathomechanisms remain undefined, some major contribut-
ing factors have been elucidated. For example, evidence of a
signaling cascade triggered by amyloid deposits, resulting in
neuroinflammation and microtubule-associated tau protein
hyperphosphorylation, is a likely major underlying process
contributing to AD pathogenesis [2]. An element of this phe-
nomenon is amyloid precursor protein (APP), a transmem-
brane component of the outer membrane of the cell. Also,
the mitochondria is cleaved by three enzymes 𝛼-, 𝛽-, and
𝛾-secretases, with variable cleavage outcomes, determined
by as-yet undefined factors. Exploration of this enzymatic
activity reveals that cleavage by 𝛼-secretase prevents amyloid
𝛽-formation—and themain products of cleavage by𝛽- and 𝛾-
secretases include A𝛽40 and A𝛽42, which are secreted extra-
cellularly, and may form aggregations that contribute to neu-
rological tissue damage [3–5].
Tau protein aggregation is promoted by amyloid 𝛽, which
may directly or indirectly activate protein kinases, such as
GSK3 and CDK5, via elevation of intracellular calcium levels,
leading to tau-hyperphosphorylation and aggregate forma-
tion [6, 7]. Once tau aggregation is initiated, the resulting
cascade becomes self-sustaining, continuing independently
of amyloid 𝛽 presence [2]. Rogers et al. described how amy-
loid 𝛽 and its N-terminal fragments bind to C1q, thus directly
activating the complement system and downstream neuroin-
flammatory processes that play roles in evolution of the dis-
ease [8]. As a result of these events, microglial and astrocytic
activation of the kinase/phosphatase activity can be altered,
resulting in further hyperphosphorylation and tau protein
aggregation [9].
Several studies have demonstrated that oxidative stress,
mitochondrial dysfunction, and inappropriately high proin-
flammatory activity synergize to damage macromolecu-
les on which healthy cellular and tissue function are depend-
ent—including nucleic acids, lipids, and proteins, ultimately
causing neurodegeneration [10–12].
Ongoing characterization of AD and other neurodegen-
erative disorders have revealed that therapeuticmanipulation
of the heme oxygenase/biliverdin reductase (HO/BVR) sys-
tem holds enormous potential for prevention and remedia-
tion of these diseases. HO is a major cellular cytoprotectant,
the upregulation of which is an early event of the adaptive
response to stress [13]. In humans, rodents, and many other
species, HO exists as two main isoforms: HO-1, an inducible
form, and HO-2, which is a constitutively active form. Both
isotypes catalyze degradation of heme into biliverdin-alpha
(BV-alpha), carbon-monoxide (CO), and ferrous ion [Fe(II)].
HO-1, also known as heat shock protein-32 (Hsp-32) is
expressed at increased levels in response to internal or exoge-
nous stress cues, including the following: oxidative stress,
ischemia, reperfusion, thermal effects, bacterial lipopolysac-
charide, and the presence of hemin, its main substrate, which
accumulates in tissues as a result of red blood cell turnover
[14]. HO-2 expression is observed to increase in response
to developmental factors, adrenal glucocorticoids, and nitric
oxide (NO) [15, 16]. The gene coding for HO-1, HMOX1, has
two upstream enhancer regions—E1 and E2—which contain
antioxidant-responsive elements supporting the oxidative-
inducible nature of this protein [17]. Maines suggested that
HO-1 plays a pivotal role in the earliest phases of home-
ostatic adaptive responses that have evolved to limit tissue
damage, while HO-2 is more likely to act as a housekeeping
molecule in ways that contribute to the maintenance of heme
homeostasis [18]. CO, which is a major metabolite resulting
fromHO-mediated degradation of heme, regulates important
mechanisms in the central nervous system. These include
long-term hippocampal potentiation and neurotransmitter
release. HO also functions in the peripheral nervous sys-
tem to catalyze a diverse range of vital activities, such as
the following: nonadrenergic, noncholinergic gastrointestinal
relaxation; vasodilation; and inhibition of platelet aggrega-
tion. Moreover, the enzyme acts to limit apoptotic depletion
of healthy cells in response to oxidative stressors, along with
other cytoprotective functions [19–23].
HO-mediated heme degradation produces biliverdin,
which is almost immediately reduced to bilirubin (BR)
by biliverdin reductase (BVR). Two BVR isoforms have
been described: BVR-A and BVR-B. However, only BVR-
A reduces BV-alpha into BR, which is a strong antioxi-
dant and antinitrosative molecule [24]. Several investigations
have demonstrated that accumulation of amyloid 𝛽 acts to
increase HO-1, in a physiologic regulatory feedback process
which ameliorates the harmful effects of amyloid 𝛽 [25, 26].
Additionally, many studies which describe the protective
role of physical activity as a countermeasure to AD-related
neurodegenerative processes include underlying cellular and
molecular mechanisms in which HO activity is a potential
factor for humans and in animal models of AD [27]. The
signaling events linking physical activity with reduction in
severity of AD include activity of the Wnt pathway, along
with influences that suppress aberrant neuronal apoptosis
or decrease amyloid 𝛽 accumulation through its enzymatic
degradation and improvement of synaptic plasticity and neu-
rogenesis [28–30], or by increasing the expression of sirtuin-
1/peroxisome proliferator-activated receptor gamma coacti-
vator 1-alpha (SIRT-1/PGC-1𝛼) signaling, therefore inhibiting
amyloid 𝛽 production [31].
Insight into the above events is likely to yield improved
understanding to AD etiology which, at the time of this writ-
ing, remains substantially obscure. Most cases of AD occur
spontaneously, with triggering events that are poorly defined
or unknown. Familial susceptibility to the disorder occurs,
but it is definitively implicated in only 1–5% cases [32]. Several
animal models have proven to be suitable investigative tools
for research into AD pathogenesis. The most widely used
animals for modeling AD are mice and rats. Due to the lack
of complete understanding of AD pathomechanisms, all of
these models have significant limitations. However, careful
selection of a particular animal model in the context of a
particular AD-related hypothesis to be tested may reduce the
influence of confounding factors associated with a particular
model. For example, the numerous transgenic mouse models
exhibit features that make them particularly useful in charac-
terizing the familial form of AD, while healthy animals that
are subjected to treatments such as streptozotocin- (STZ-)
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induced neurodegenerationmay be used to demonstrate phe-
notypic characteristics of the spontaneously occurring forms
of AD [33]. The authors of the present investigation selected
a model in which neurodegeneration occurred naturally,
though advanced age (18-month-old rats), thus avoiding the
potentially confounding influences of transgenes or drugs.
The present investigation was structured to test a hypoth-
esis that voluntary (recreational) physical activity (treadmill
exercise) ameliorates neurodegeneration-related cognitive
decline and associated major neuropathological alterations
by decreasing oxidative stress via increasing HO-1 activity,
thereby preventing neuronal loss in the brain of aging rats.
This is the first study to evaluate this possibility using an
animal model as a correlation between physical exercise
and molecular-biological effects associated with age-related
neurodegeneration.
2. Materials and Methods
2.1. Animals. 18-month-old male and female Wistar rats,
weighing 300–350 grams at the outset of each experiment,
were housed two per cage at an ambient temperature of
22–24∘C under a 12 h : 12 h light : dark cycle with food and
water ad libitum.
2.2. Treatment Group Assignment. Animals used in the
present study were segregated into six groups, defined as
follows: (i) aged sedentary female rats (ASF, 𝑛 = 8); (ii) aged
sedentary male rats (ASM, 𝑛 = 8); (iii) aged running female
rats (ARF, 𝑛 = 8); (iv) aged running male rats (ARM, 𝑛 = 8);
(v) young (3 months old) control female rats (YCF, 𝑛 = 8);
and (vi) young (3 months old) control males (YCM, 𝑛 = 8).
Rats in the ARF and ARM groups had free availability to a
standardized inbuilt running wheel and were able to exercise
freely, whereas animals in the ASF and ASM groups were
housed without access to running wheels. All groups were
maintained in the above described conditions for 3-month
periods.
2.3. Behavioral Tests. Here, the Morris Water Maze (MWM)
test was used as a primary measure of memory function by
animal subjects. MWM data is here considered to be partic-
ularly valuable, since it is one of the most frequently used
learning and spatial memory assessments for rodent models,
and it is acknowledged to produce reliably reproducible
outcomes [34].MWMevaluationswere conducted as follows:
a circular pool, 150 cm in diameter, 50 cm in height, in a small
quiet room, is filled with opaque water at room temperature,
to a depth of 30 cm, and divided into four quadrants. An
invisible platform, 10 cm in diameter, is submerged 1 cm
below the surface, in the middle of one of the four quadrants.
The position of the platform is kept unaltered throughout
a training session, during which time each animal becomes
familiar with structural features and visual cues, memories
of which are the basis of the test. Selected visual cues are
placed on the inner wall of the pool to indicate the four
quadrants and provide navigation reference points, which the
rats will remember to varying degrees, depending on their
neurological capacity. MWM tests were carried out during
three consecutive days, twice a day before the treatment
(baseline), and after the 3 months of voluntary running on
wheels installed in cages. For each trial, the animals were
gently put into thewater at one of the four starting points (that
differed for each test—the sequences for which were selected
randomly).The tests were scored on the basis of ability of the
animals to locate the submerged platform. Each animal was
allowed a 10-second rest period on the platform. If an animal
was unable to locate a platform within a 60-second interval,
it was gently guided and placed on it. Escape latency time
and swimming patterns were measured by a video tracking
system (EthoVision 2002, Noldus Information Technology,
Netherlands).
2.4. Small Animal PET Imaging Using Radiopharmaceuticals.
Rats were injected with 10.0 ± 0.2MBq of [11C]PIB via the
lateral tail vein. 30 minutes following injection of the radio-
tracer, the animals were anaesthetized using 3% isoflurane
with a dedicated small animal anesthesia device. Next, 15-
minute static single-frame PET scans were acquired using
a small animal PET scanner (MiniPET-II) to visualize the
brain. Scanner normalization and random correction were
applied on the data, and the images were reconstructed with
the standard EM iterative algorithm. The pixel size was 0.5 ×
0.5 × 0.5mm, and the spatial resolution varied between 1.4
to 2.1mm from central to 25mm radial distances.The system
sensitivity is 11.4% [35].
2.4.1. PET Data Analysis. Radiotracer uptake was expressed
in terms of standardized uptake values (SUVs). Ellipsoidal 3-
dimensional volumes of interest (VOI) were manually drawn
around the edge of the brain activity by visual inspection
using BrainCad software. The standardized uptake value
(SUV) was calculated as follows: SUV = [VOI activity
(Bq/ml)]/[injected activity (Bq)/animal weight (g)], assum-
ing a density of 1 g/cm3.
2.5. Histology Studies: Hematoxylin-Eosin and Congo Red
Staining. Following the MWM test at the end of the three-
month recreational exercise, the rats were deeply anesthetised
and transcardially perfused with 10ml of 4∘C PBS, followed
by 30ml of 4∘C paraformaldehyde solution (4% in phosphate
buffer, pH7.4). Rat brainswere removed and bisected into two
halves. The right hippocampal, frontal, and temporal lobes
were removed and postfixed for 24 hours in the same fixative
(4∘C) and subsequently placed in a 30% sucrose solution for
72 hours at 4∘C in PBS. Formalin-fixed, paraffin-embedded
brain tissue blocks (FFPE) were then microtomed into 7 𝜇m
thick sections and stained with hematoxylin-eosin (H&E)
and Congo red (Sigma-Aldrich) for detection of amyloid-
related pathology.The sections were placed on slides, dried at
37∘Covernight, then rehydrated using a graded alcohol series,
and then stained with hematoxylin for 3 minutes. Sections
were rinsed in running tap water for 10 minutes until they
turned blue and then stained with eosin for 3minutes. Congo
red-stained sections were subsequently counterstained with
hematoxylin for 3 minutes, rinsed in running tap water
to develop blue coloration, washed twice in distilled water,
and stained with Congo red for 40 minutes. The stained
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sections were subsequently analyzed by light microscopy.
Examination of Congo red-stained tissues was conducted
using polarized light. Semiquantitative analysis of amyloid
pathology was accomplished by first counting the number of
amyloid plaques and Congo red-positive vessels as a fraction
of the total number of vessels observed in 10 fields, using a 10x
objective (100x magnification). The resulting percentage of
Congo red-positive vessels within the total number of vessels
(number of positive vessels/total vessel number× 100) yielded
quantitative data that allowed assignment of tissues into 4
different categories, described as follows: (i) tissue with no
(0%) positive vessels (-); (ii) tissue with 1–29% (low number
of positive vessels) (+); (iii) tissue with 30–69% (moderate
number of positive vessels) (++); and (iv) tissue with more
than 70% (numerous positive vessels) (+++).
2.6. Immunohistochemical Study. Immunohistochemistry
(IHC) has been performed according to standardized
methods. In brief, 7 𝜇m thick sections from formalin-fixed,
paraffin-embedded blocks have been stained for anti-beta
amyloid 1–42 antibody (Abcam, 1 : 200) according to the
manufacturer’s protocol. The stained sections were analyzed
by light microscopy. Semiquantitative analysis of amyloid
pathology was accomplished by a similar method to that of
the Congo red staining. We counted the number of anti-beta
amyloid 1–42 antibody-positive vessels as a fraction of the
total number of vessels observed in 10 fields, using a 10x
objective (100x magnification).
The resulting percentage of positive vessels within the
total number of vessels (number of positive vessels/total
vessel number × 100) yielded quantitative data that allowed
assignment of tissues into 4 different categories, described as
follows: (i) tissue with no (0%) positive vessels (-); (ii) tissue
with 1–29% (low number of positive vessels) (+); (iii) tissue
with 30–69% (moderate number of positive vessels) (++); and
(iv) tissue with more than 70% (numerous positive vessels)
(+++).
2.7. Measurement of Heme Oxygenase Activity. Awidely used
and reliable assay for HO-1 activity, based on the reduction of
biliverdin into bilirubin, was used for the present study [36].
Following the sacrifice of each animal, the frontal cortex, tem-
poral cortex, and hippocampus of harvested brains were iso-
lated and homogenised (Ultraturrax T25; 13,500/s; 2 × 20 s).
Samples from the left hemispheres of each brain were pro-
cessed using 10mM N-[2-hydroxyethyl]piperazine-N󸀠-[2-
ethanesulfonic acid] (HEPES), 32mM sucrose, 1mM dithio-
threitol (DTT), 0.1mM EDTA, 10 𝜇g/ml soybean trypsin
inhibitor, 10 𝜇g/ml leupeptin, and 2 𝜇g/ml aprotinin, pH
7.4. The supernatant was collected by centrifugation for 30
minutes at 20,000×g at 4∘C. Each reactionmixture contained
the following in a final volume of 1.5ml : 2mM glucose 6-
phosphate, 0.14U/ml glucose 6-phosphate dehydrogenase,
15 𝜇M heme, and 150 𝜇M 𝛽-nicotinamide adenine dinu-
cleotide phosphate (NADPH). 120 𝜇g/ml rat liver cytosol
was used as a source of biliverdin reductase, with 2mM
MgCl
2
, 100mM potassium phosphate buffer, and 150𝜇l of
supernatant. Incubation was carried out in the dark at
37∘C for 60 minutes. The reaction was stopped by putting
samples on ice.The bilirubin formed was calculated from the
difference between optical densities obtained at 460 nm and
530 nm. One unit of heme oxygenase activity was defined as
the amount of bilirubin (nmol) produced per hour per mg of
protein.
2.8. Graphs and Statistical Analysis. For statistical analysis
andfigure plotting,GraphPadPrism7.03 Software (GraphPad
Prism Software Inc., California, USA) was used. All data were
expressed as means ± SEM. Two data sets were compared
with unpaired Student 𝑡-test or 𝑡-test with Welch’s correction
(if equal variance test was not passed). More than two data
sets were compared with one-way ANOVA (using Geisser-
Greenhouse correction) with Tukey post hoc testing. (All
data sets passed the D’Agostino-Pearson omnibus normality
test.)
3. Results
3.1. Voluntary Exercise Improves Spatial Learning andMemory
in the Aging Model of Alzheimer’s Disease. Following 3
months of voluntary exercise, rats were assessed for spa-
tial learning and memory using the Morris Water Maze
test. Assessments based on swim time to find submerged
platforms (escape latency) were followed with a tracking
system. Escape latency scores revealed a significant correla-
tion between voluntary exercises on the three training days
of the MWM test protocol (Figure 1). Animals within the
aged sedentary group (including both male and female rats)
required significantly more time to find the platform and
were not able to improve their learning ability (𝑝 < 0.001).
However, animals in the aged running groups (both males
and females) were more likely to find the platform within
decreasing time compared to the sedentary aging groups
(mean differences: Day 1: 10.15 seconds, 𝑝 = 0.038, and 14.60,
𝑝 < 0.01; Day 2: 28.45, 𝑝 < 0.001, and 25.45, 𝑝 < 0.001;
Day 3: 30.25, 𝑝 < 0.001, and 33.55, 𝑝 < 0.001 for males and
females, respectively.
3.2. 11C-Pittsburgh Compound-B PET Region of Interest (ROI)
Analysis in Amyloid Imaging. Figure 2 shows PET scan
images of rat brains belonging to each test group used. PIB
radionuclide retention was significantly higher among aged
sedentary animals than among young control rats (SUV
mean of PIB for aging females: 0.87 ± 0.029 and for young
control females: 0.43 ± 0.02). Figure 3(a) shows data for aged
males: 0.97 ± 0.024 and for young control males: 0.41 ±
0.01 (Figure 3(b): 𝑝 < 0.001 for both males and females).
Analysis of data from animals in the aged running groups
revealed significantly lower PIB retention (𝑝 = 0.0119 and
𝑝 < 0.001, for males and females, resp.) than in the young
groups.
It is nevertheless important to caveat the above results
with a corollary observation: that rat brain PIB retention of
aged runningmale and female rats showed no significant cor-
relation with the spatial learning and memory exhibited by
these animals. Agedmale and female running rats performed
equally well in the Morris Water Maze test.
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Figure 1: Effect of recreational exercise on Morris Water Maze performance. AS, aged sedentary; AR, aged running; YC, young control. ∗
means 𝑝 < 0.05 compared to the control, ∗∗means 𝑝 < 0.01 compared to the control, and ∗ ∗ ∗∗means 𝑝 < 0.001 compared to the control.
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Figure 2: PET images (one coronal, two horizontal sections in each picture) of aged sedentary female (ASF) and male (ASM) rats (a, c), aged
running female (ARF) and male (ARM) rats (b, d), and a young control animal (e).
3.3. Voluntary Exercise Ameliorated the Neurodegenerative
Histopathological Changes in the Brains of Aging Rats. The
sagittal sections of aged sedentary (AS) and aged running
(AR) animals were examined by lightmicroscopy, usingH&E
and Congo red staining. H&E staining revealed remarkable
degenerative abnormalities in theAS groups, compared to the
young control animals (see Figures 4(a) and 4(b)). Disinte-
gration of the pyramidal layer structure, neuronal loss, and
severe pericellular edema was observed in the dentate gyrus
(see Figures 4(c) and 4(d)). However, following the 3 months
of voluntary exercise, these changes were attenuated to some
extent. Cellular substructure of tissues from rats allowed
exercising displayed significantly tighter organization, along
with lower levels of pericellular edema (Figures 4(e) and 4(f)).
The accumulation of amyloid in rat brains demonstrated by
Congo red staining failed to demonstrate amyloid plaques.
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Figure 3: Effect of recreational exercise on PIB retention. (a) Aged males and (b) aged females. AS, aged sedentary; AR, aged running; YC,
young control. ∗means 𝑝 < 0.05 compared to the control and ∗ ∗ ∗∗means 𝑝 < 0.001 compared to the control.
(a)
(b)
(c)
(d)
(e)
(f)
Figure 4: Hematoxylin-eosin stained sections (100x magnification). (a-b) Hippocampus of a young control male and a female animal,
respectively. (c-d) Hippocampus of an aged sedentary male and a female rat, respectively. (e-f) Hippocampus of an aged running male and a
female animal, respectively.
However, age-related cerebral amyloid angiopathy (CAA)
was detectable, as revealed in Figure 5. The aged sedentary
animals (AS)—both females and males—exhibited a mod-
erate number of Congo red-positive vessels (32.4 ± 2.237%
in males and 27 ± 0.89% in females). By contrast, tissues
from animals in the running groups possessed significantly
lower density of Congo red-positive vessels (13.60 ± 0.77% in
males and 7.8 ± 0.57% in females) and their Congo positivity
was less intense. Statistical analysis of the results proved
that the difference between the aged sedentary and aged
running groups was significant both in the case of males
(𝑝 < 0.001) and in the case of females (𝑝 < 0.001) (Figure 6.).
Age-related cerebral amyloid angiopathy (CAA) was also
detectable by immunohistochemistry (Figure 7.). The aged
sedentary animals (AS)—both females and males—exhibited
a moderate number of Congo red-positive vessels (31.6 ±
1,78% in males and 27,1 ± 0.9% in females). However, tissues
from the running aging groups possessed significantly lower
density of anti-beta amyloid 1–42 antibody-positive vessels
(14.70 ± 0.47% in males and 8 ± 0.55% in females). The
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Figure 5: Cerebral amyloid angiopathy represented by Congo red staining (100x magnification). (a-b) Aged sedentary male and female brain
sections under polarized light. The bright regions in the vessel walls marked by the black arrowheads can be identical to amyloid-like
depositions. (c-d) Aged runningmale and female brain sections under polarized light.The black arrowheads are pointing to vessels containing
lesser amount of amyloid-like depositions.
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Figure 6: Statistical analysis of CAA. ∗∗∗𝑝 < 0.001; ∗∗∗∗𝑝 < 0.001.
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Figure 7: Cerebral amyloid angiopathy represented by immunohistochemistry (100x magnification). (a-b) Brain section from a young control
male and a female animal, respectively. (c-d) Brain section from an aged sedentary male and a female rat, respectively. (e-f) Brain section
from an aged running male and a female animal, respectively. The brownish color represents the amyloid-like depositions in the vessel walls.
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Figure 8: Statistical analysis of CAA immunohistochemistry. ∗∗∗𝑝 < 0.001; ∗∗∗∗𝑝 < 0.001.
difference between the aged sedentary and aged running
groups was statistically significant both in the case of males
and in the case of females (Figure 8).
3.4. Effects of Voluntary Exercise on HO-1 Activity. Relatively
low activity of the heme oxygenase-1 enzyme was observed
in the frontal cortex and hippocampus of aged sedentary rats
both in females (1.3±0.08 and 0.95±0.02 nmol/h/mg protein,
resp.) and in males (0.8 ± 0.03 and 0.72 ± 0.04 nmol/h/mg
protein, resp.). Interestingly, three months of voluntary exer-
cise correlated significantly with increased activity of this
enzyme, both in females (2.49 ± 0.08, 𝑝 < 0.001, and
1.53 ± 0.06 nmol/h/mg protein, 𝑝 < 0.001, resp.) and in
males (1.35 ± 0.1, 𝑝 < 0.001, and 0.99 ± 0.04 nmol/h/mg
protein 𝑝 < 0.001, resp.). Moreover, within the temporal
cortex, excluding the hippocampus, higher HO-1 activity was
noted both in females (9.18 ± 0.39 nmol/h/mg protein) and
in males (8.80 ± 0.19 nmol/h/mg protein). Nevertheless, no
correlation was observed between HO-1 activity and exercise
status for the above conditions either in females (9.08 ±
0.11 nmol/h/mg protein) or in males (9.2 ± 0.34 nmol/h/mg
protein) (Figure 9.).
4. Discussion
Alzheimer’s disease (AD) is a chronic neurodegenerative
disorder that is the most common cause of dementia in the
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Figure 9: Heme oxygenase-1 enzyme activities of the indicated experimental groups categorized by brain regions. ASF, aged sedentary females;
ARF, aged running females; ASM, aged sedentary males; ARM, aged running males. ∗∗∗𝑝 < 0.001; ####𝑝 < 0.001.
elderly, and it is clinically characterized by progressive loss of
cognitive ability, including memory, communication, judge-
ment, and reasoning. Features of the disorder include mood
swings, personality disorders, and progressively adverse
behavior. During the late stages of the disease, afflicted
individuals may become unable to care for themselves [37].
The underlying pathomechanisms of this tragic syndrome
appear to include accumulation of amyloid-𝛽 oligomers and
aggregation of this material into plaques, which disrupt the
metabolism of affected cells in ways that promote neuroin-
flammation. These processes trigger hyperphosphorylation
of the tau protein, which normally plays a role inmicrotubule
stabilization, but, withAD-associated hyperphosphorylation,
it mediates synaptic dysfunction and cell death [38].
Numerous animal models, such as drug-treated rodents
(e.g., STZ-treated rats) and various transgenic animals (e.g.,
APP (swe)/PS1(e9d)1 transgenicmouse strain, Tg2576mouse
model) [39, 40], have been developed to parallel the patho-
genesis of human Alzheimer’s disease in ways that allow their
use in creation of novel preventive and therapeutic strategies.
Nevertheless, optimal utilization of such animals is cur-
rently constrained by lack of clear, mechanistic insight into
AD pathomechanisms [33]. Moreover, most human AD
cases occur spontaneously, without clearly defined etiologic
contributors. Indeed, only 5% of these patients are positively
diagnosed with the familial form of the disease. Thus, the
present study examined neurodegenerative changes in an
aging rat model, in which the animals underwent deteriora-
tion of cognitive functions that have significant commonality
with AD but occur naturally and thus have better relevance
to clinical aspects of spontaneously occurring human AD
than drug-induced and transgenic models. The precedent
for use of the aging rat as an investigative tool for AD is
well established. For instance, Sapronov et al. demonstrated
that chronic combined administration of 8-OH-DPAT, a
serotonin 5HT (1A) receptor agonist, with galantamine,
resulted in pronounced antidepressant and anxiolytic action
in an aging rat model of Alzheimer’s disease [41]. Moreover,
Gocmez et al. used this model to characterize the role of
neuroinflammation and reactive oxygen species (ROS) in the
pathogenesis of Alzheimer’s-type dementia and the effect of
resveratrol in decreasing neuroinflammation and preserving
cognitive functions of aging rats [42].
A major result of the present study was an observation
that elderly animals manifest typical features of dementia.
This conclusion was made via use of assays for spatial and
learning memory, by direct examination of PET scan images,
or histopathological analysis of brain tissue. For example,
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it was observed that aged rats (both males and females)
exhibit Morris Water Maze (MWM) test performance scores
significantly worse than those of young rats.
PET scans utilized here revealed significantly high accu-
mulation of amyloid beta in the brains of elderly rats, and
histopathological examination of their brain tissue provided
novel insight into the extent of neurodegenerative lesions.
This included disintegration of the pyramidal layer structure,
neuronal loss, and severe pericellular edema in the dentate
gyrus, as well as cerebral amyloid angiopathy (CAA). The
present study additionally revealed age-related decrease in
HO-1 activity within the frontal and parietal cortex and
hippocampus.
The above results notwithstanding—and despite sig-
nificant accumulation of radiolabeled PIB during PET
imaging—amyloid plaques were undetectable in the brain
tissues by histopathological examination. One explanation
for this result might be that PIB cannot differentiate between
extracellular amyloid plaques and aggregated amyloid-𝛽
accumulated in the vessel walls. This conclusion is, neverthe-
less, speculative and is the subject of ongoing analysis of AD
by authors of this report.
Physical exercise ameliorated the cognitive decline in
the aged rats. The animals in the aged running (AR) group
required significantly shorter escape latency time to remem-
ber locations of hidden platforms in the Morris Water Maze
test than the aged sedentary (AS) rats, irrespective of their
gender. This finding is supported by other recent studies. For
example, Yosefi et al. demonstrated that 4-week treadmill
running improved the spatial learning and memory of rats
with icv, STZ-induced cognitive impairment [43]. Hoveida et
al. also demonstrated that daily treadmill exercise for 60 days
attenuated cognitive decline caused by bilateral lesions in the
nucleus basalis Meynert, which represents another model of
Alzheimer’s disease [44].
Experiments conducted in this study showed that recre-
ational exercise significantly decreased PIB retention in the
brain of aged running animals, in comparison to aged seden-
tary animals. This outcome suggests that brains of animals
that were allowed to exercise accumulated lower amounts
of insoluble amyloid-𝛽 than did sedentary animals. Daily
running also attenuated deleterious neuropathological alter-
ations found in the brain tissues of aged rats. Disintegration
of the pyramidal layer structure, neuronal loss, and severe
pericellular edema in the dentate gyrus of the hippocampus,
as well as cerebral amyloid angiopathy (CAA)—represented
by Congo red staining and immunohistochemistry—were
significantly mitigated by physical activity. The effect of
delaying neurodegeneration or restoring synaptic function
and neuronal integrity has previously been attributed to
physical exercise by numerous studies. For example, Lin et al.
reported that regular physical activity restores hippocampal-
and amygdala-associated memory and dendritic arbor, along
with reducing the severity of edema and neuronal loss
[45]. Further, Li et al. demonstrated that moderate exercise
improved cognitive function, decreased neuronal apoptosis,
and increased synapse numbers in a D-galactose-induced
aging mouse model [46].
Oxidative stress, mitochondrial dysfunction, and
hyperinflammatory processes constitute a positive feed-
back process that may be described as a vicious circle,
which increases the extent of amyloidogenesis and tau-
hyperphosphorylation, leading to neuronal impairment, cell
death, and neurodegeneration. This phenomenon has been
described by several previous studies to be a major feature
of Alzheimer’s disease [47–50]. Recent investigations also
suggest that HO-1 activity is one of the most important
adaptive physiologic countermeasures to AD-associated
oxidative stress [51, 52]. Production and biological activation
of HO-1 may be induced by a wide range of external and
endogenous influences, including oxidative stress, ischemia,
heat shock, bacterial lipopolysaccharide, and the presence of
hemin, which is the main substrate of heme oxygenases. This
enzyme is the rate-limiting macromolecule in heme catab-
olism and also plays important roles in cell respiration, dif-
ferentiation processes, energy production, and oxidative
biotransformation [14].
For these reasons, natural or pharmacological induction
of HO-1 offers enormous promise for prevention and man-
agement of many serious chronic diseases, including AD
[53, 54]. Many recent studies support this broad objective.
For example, Bhardwaj et al. showed that pharmacological
induction of HO-1 by hemin decreased oxidative stress and
restored cognitive function in an intracerebroventricular
streptozotocin-infused rat model of Alzheimer’s disease [55].
The authors of the present report conducted the study
on which it is based, in part to further demonstrate the
future potential of HO-1-based strategies for dealing with
the technical challenges posed by AD. Here, the investigators
demonstrated significantly increased HO-1 enzyme activity
levels in the frontal cortex and hippocampus of aged running
rats. Together with the attenuation of cognitive decline,
imaging, and neuropathological alterations, the results of
these experiments suggest that the severity of age-related
Alzheimer’s-type dementia may be mitigated by augmen-
tation of naturally occurring HO-1 activity, with outcomes
expected to include significantly reduced oxidative stress and
reduced severity of AD symptoms.
It has long been known that physical exercise confers
many beneficial effects on health. Studies demonstrate that
exercise improves cardiovascular function [56], cognitive
ability [27], and insulin resistance and symptoms ofmetabolic
syndrome [57] and decreases the severity of neuropsychiatric
problems, including depression [58]. Di Loreto et al. demon-
strated that regular physical activity potently augmented
neuroprotective functions as a correlate of age-related amy-
loidogenesis and additionally preserved synaptic function
[59]. In related studies, Maesako et al. showed that sustained
voluntary exercise partly counteracted the effects of a high-fat
diet-induced cognitive impairment in APP-overexpressing,
transgenic mice. Interestingly, this effect was revealed to
occur not by decreasing amyloidogenesis but by increasing
the activity of an amyloid-𝛽metabolizing enzyme, neprilysin
[60]. The present investigation uses the above-mentioned
reports as a framework for a comprehensive effort by the
authors of this report to develop HO-1 inducers as a main-
stay of prevention and therapy of serious chronic disease.
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Moreover, at the time of this writing, this investigation is
the first ever to examine mechanisms of association between
physical activity and HO-1 effects. The outcomes shown here
demonstrate that HO-1 activity is significantly increased as
a result of voluntary running in aging rats and thus has
potential for future strategies to treat cognitive decline in AD
and related disorders.
5. Conclusion
Outcomes of the present study suggest that voluntary running
might increase cerebral HO-1 activity at levels that may
mitigate oxidative stress present in the brain of rats with age-
related Alzheimer’s-type dementia.
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